Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN112645909B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel nickel-catalyzed route offers air-stable efficiency for pharmaceutical intermediates, reducing cost and improving supply chain reliability for global buyers seeking scalable solutions.
Patent CN112645909B details air-stable nickel catalysis for alpha-benzylbenzofuran. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.